9 Meters Biopharma, Inc.
COMPOUNDS AND METHODS FOR TREATING TIGHT JUNCTION PERMEABILITY

Abstract:

The present invention provides Larazotide derivative compositions that resist protease degradation, and in various embodiments, do not demonstrate an inverse dose response, and/or can be delivered at higher doses without loss of potency or efficacy, thereby allowing improved therapy more desirable dosing schedules.